Robert B Carter insider trades
Open-market stock purchases and sales by Robert B Carter, Director at Quest Diagnostics Inc, from SEC Form 4 filings since Mar 22, 2010.
Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +195%.